Albuquerque, NM, United States of America

Fei Hung Chu

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Actoprobe LLC. Active years: 2021-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fei Hung Chu: Innovator in Atomic Force Microscopy

Introduction

Fei Hung Chu is a prominent inventor based in Albuquerque, NM (US). He has made significant contributions to the field of atomic force microscopy (AFM) with his innovative patents. With a total of 2 patents, his work focuses on integrating advanced technologies to enhance nanoscale measurements.

Latest Patents

Fei Hung Chu's latest patents include the "Integrated III-V/silicon atomic force microscopy active optical probe." This invention integrates a III-V semiconductor laser source and a silicon cantilever AFM probe into a single chip, facilitating AFM measurements, optical imaging, and spectroscopy at the nanoscale. Another notable patent is the "Monolithic atomic force microscopy active optical probe," which monolithically integrates various components, including a semiconductor laser source and a photodetector, into a robust semiconductor chip for enhanced AFM capabilities.

Career Highlights

Fei Hung Chu is associated with Actoprobe LLC, where he continues to push the boundaries of AFM technology. His work has garnered attention for its potential applications in various scientific fields.

Collaborations

Fei Hung Chu has collaborated with notable colleagues, including Alexander A Ukhanov and Gennady A Smolyakov, contributing to advancements in their shared field of expertise.

Conclusion

Fei Hung Chu's innovative work in atomic force microscopy exemplifies the impact of integrating technology to advance scientific research. His contributions continue to shape the future of nanoscale measurements and imaging.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…